UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1908 Effect of adjuvant concomitant treatment with radiotherapy and trastuzumab on cardiotoxicity in patients with breast cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S302-S302

2015

Volltextzugriff (PDF)

P278 Early Integrated Rehabilitation Helped Breast Cancer Patients to Start Healthy Lifestyle– A Comparison Between the Intervention and Control Group in a Prospective Study

Breast (Edinburgh), 2023-04, Vol.68, p.S127-S127

2023

Volltextzugriff (PDF)

A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial

Annals of oncology, 2018-03, Vol.29 (3), p.661-668

2018

Volltextzugriff (PDF)

3234 The impact of translocation t(14;18) on the outcome of follicular lymphoma patients

European journal of cancer (1990), 2015-09, Vol.51, p.S660-S660

2015

Volltextzugriff (PDF)

THE PROGNOSTIC VALUE OF FLIPI IN THE ERA OF RITUXIMAB

Hematological oncology, 2017-06, Vol.35 (S2), p.369-369

2017

Volltextzugriff (PDF)

Pneumocystis Jirovecii Pneumonia in Renal Transplant Recipients: A National Center Experience

Transplantation proceedings, 2013-05, Vol.45 (4), p.1614-1617

2013

Volltextzugriff (PDF)

1836 Surgery and systemic therapy improve overall survival of HER2-positive breast cancer patients with central nervous system metastases

European journal of cancer (1990), 2015-09, Vol.51, p.S278-S278

2015

Volltextzugriff (PDF)

Treatment of Hyperparathyroidism With Cinacalcet in Kidney Transplant Recipients

Transplantation proceedings, 2010-12, Vol.42 (10), p.4078-4082

2010

Volltextzugriff (PDF)

S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients

Cytopathology (Oxford), 2008-10, Vol.19 (5), p.294-302

2008

Volltextzugriff (PDF)

207P 10-year real-world outcomes with neoadjuvant systemic therapy in non-inflammatory breast cancer

Annals of oncology, 2020-09, Vol.31, p.S324-S325

2020

Volltextzugriff (PDF)

Prognostic and predictive value of cathepsins D and L in operable breast cancer patients

Neoplasma, 2005, Vol.52 (1), p.1

2005

Volltextzugriff (PDF)

Early integrated rehabilitation helps maintain good cognitive function in breast cancer patients – a comparison of self-reported cognitive function between the intervention group and control group in a prospective study in 511 patients

European journal of cancer (1990), 2022-11, Vol.175, p.S41-S42

2022

Volltextzugriff (PDF)

Prognostic Value of the Urokinase-Type Plasminogen Activator, and its Inhibitors and Receptor in Breast Cancer Patients

Clinical breast cancer, 2002-06, Vol.3 (2), p.138-146

2002

Volltextzugriff (PDF)

Prognostic significance of plasminogen activator inhibitor-1 in breast cancer, with special emphasis on locoregional recurrence-free survival

The International journal of biological markers, 2002, Vol.17 (1), p.33-41

2002

Volltextzugriff (PDF)

497 Possible predictive role of prior endocrine therapy on fulvestrant treatment outcome

European journal of cancer supplements, 2010, Vol.8 (3), p.204-205

2010

Volltextzugriff (PDF)

Prognostic and predictive value of the urokinase-type plasminogen activator (uPA) and its inhibitors PAI-1 and PAI-2 in operable breast cancer

The International journal of biological markers, 2003-04, Vol.18 (2), p.106-115

2003

Volltextzugriff (PDF)

347P - Multicenter phase I trial of trastuzumab emtansine (T-DM1) in combination with non-pegylated liposomal doxorubicin (NPLD) in HER2[+] metastatic breast cancer (MBC). THELMA study

Annals of oncology, 2019-10, Vol.30, p.v124-v125

2019

Volltextzugriff (PDF)

Multicenter phase I trial of trastuzumab emtansine (T-DM1) in combination with non-pegylated liposomal doxorubicin (NPLD) in HER2[+] metastatic breast cancer (MBC). THELMA study

Annals of oncology, 2019-10, Vol.30, p.v124-v125

2019

Volltextzugriff (PDF)

347PMulticenter phase I trial of trastuzumab emtansine (T-DM1) in combination with non-pegylated liposomal doxorubicin (NPLD) in HER2[+] metastatic breast cancer (MBC). THELMA study

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Abstract P6-18-16: Ribociclib (RIBO) + letrozole (LET) in older patients with hormone receptor-positive (HR+), human epidermal growth factor receptor-2–negative (HER2–) advanced breast cancer (ABC): Preliminary subgroup results from the phase 3b CompLEEment-1 trial

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-18-16

2019

Volltextzugriff (PDF)

Prognostic significance of plasminogen activator inhibitor-1 in breast cancer, with special emphasis on locoregional recurrence-free survival

The International journal of biological markers, 2002, Vol.17 (1), p.33-41

2002

Volltextzugriff (PDF)

Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study

The lancet respiratory medicine, 2019-02, Vol.7 (2), p.129-140

2019

Volltextzugriff (PDF)

Abstract P5-15-05: Randomized phase II study evaluating different schedules of nab-paclitaxel in metastatic breast cancer (MBC): Results of the SNAP study

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P5-P5-15-05

2017

Volltextzugriff (PDF)

Pneumocystis Jirovecii Pneumonia in Slovenian Renal Transplant Recipients: 2172

Transplantation, 2012-11, Vol.94 (10S), p.915

2012

Volltextzugriff (PDF)

1 – 25 von 208

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(174)
Mit Volltextzugriff
(160)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(15)
Organizacija
(11)
Clinical Nephrology
(10)
Onkologija
(10)
Cancer Research
(8)
Uporabna Informatika
(8)
The International Journal Of Biological Markers
(7)
European Journal Of Cancer
(6)
Annals Of Oncology
(5)
Breast
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

1908 Effect of adjuvant concomitant treatment with radiotherapy and trastuzumab on cardiotoxicity in patients with breast cancer

P278 Early Integrated Rehabilitation Helped Breast Cancer Patients to Start Healthy Lifestyle– A Comparison Between the Intervention and Control Group in a Prospective Study

A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial

3234 The impact of translocation t(14;18) on the outcome of follicular lymphoma patients

THE PROGNOSTIC VALUE OF FLIPI IN THE ERA OF RITUXIMAB

Pneumocystis Jirovecii Pneumonia in Renal Transplant Recipients: A National Center Experience

1836 Surgery and systemic therapy improve overall survival of HER2-positive breast cancer patients with central nervous system metastases

Treatment of Hyperparathyroidism With Cinacalcet in Kidney Transplant Recipients

S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients

207P 10-year real-world outcomes with neoadjuvant systemic therapy in non-inflammatory breast cancer

Prognostic and predictive value of cathepsins D and L in operable breast cancer patients

Early integrated rehabilitation helps maintain good cognitive function in breast cancer patients – a comparison of self-reported cognitive function between the intervention group and control group in a prospective study in 511 patients

Prognostic Value of the Urokinase-Type Plasminogen Activator, and its Inhibitors and Receptor in Breast Cancer Patients

Prognostic significance of plasminogen activator inhibitor-1 in breast cancer, with special emphasis on locoregional recurrence-free survival

497 Possible predictive role of prior endocrine therapy on fulvestrant treatment outcome

Prognostic and predictive value of the urokinase-type plasminogen activator (uPA) and its inhibitors PAI-1 and PAI-2 in operable breast cancer

347P - Multicenter phase I trial of trastuzumab emtansine (T-DM1) in combination with non-pegylated liposomal doxorubicin (NPLD) in HER2[+] metastatic breast cancer (MBC). THELMA study

Multicenter phase I trial of trastuzumab emtansine (T-DM1) in combination with non-pegylated liposomal doxorubicin (NPLD) in HER2[+] metastatic breast cancer (MBC). THELMA study

347PMulticenter phase I trial of trastuzumab emtansine (T-DM1) in combination with non-pegylated liposomal doxorubicin (NPLD) in HER2[+] metastatic breast cancer (MBC). THELMA study

Abstract P6-18-16: Ribociclib (RIBO) + letrozole (LET) in older patients with hormone receptor-positive (HR+), human epidermal growth factor receptor-2–negative (HER2–) advanced breast cancer (ABC): Preliminary subgroup results from the phase 3b CompLEEment-1 trial

Prognostic significance of plasminogen activator inhibitor-1 in breast cancer, with special emphasis on locoregional recurrence-free survival

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study

Abstract P5-15-05: Randomized phase II study evaluating different schedules of nab-paclitaxel in metastatic breast cancer (MBC): Results of the SNAP study

Pneumocystis Jirovecii Pneumonia in Slovenian Renal Transplant Recipients: 2172

Suchergebnisse filtern